Abstract: This disclosure relates to a quantum processor comprising multiple patches of digital qubits and a quantum bus of digital qubits. The quantum bus is configured to connect the multiple patches of digital qubits and to transmit quantum information constituting long-range interactions between the patches of digital qubits. The quantum processor is controlled by a first method of error correction on each of the patches connected by the bus to reduce a relatively high error rate in the digital qubits to a relatively low error rate of each patch, and by a second method of error correction on the multiple patches to correct the relatively low error rate. The number of patches can be increased to increase the distance of the second method and therefore reduce the final error rate. Due to the quantum bus, the patches can be arranged such that there is sufficient space between them for control circuitry.

Abstract: The present disclosure generally relates to nanoparticles adsorbed with gliadin molecules. In addition, the present disclosure relates to methods of preparing the nanoparticles adsorbed with gliadin molecules and methods of using said nanoparticles including detecting anti-gliadin 5 antibodies in a sample, diagnosing gluten-related disorders, and other applications.

Abstract: The present invention relates to methods of prognosing and monitoring cancer using circulating cells and/or extracellular vesicles as indicators of the progression of plasma cell neoplasms in patients.

Abstract: An electrical isolation process, includes receiving a substrate including a layer of carbon-rich material on silicon, and selectively removing regions of the substrate to form mutually spaced islands of the carbon-rich material on the silicon. The layer of carbon-rich material on silicon includes the layer of carbon-rich material on an electrically conductive layer of silicon on an electrically insulating material. Selectively removing regions of the substrate includes removing the carbon-rich material and at least a portion of the electrically conductive layer of silicon from those regions to provide electrical isolation between the islands of carbon-rich material on silicon.

Abstract: This invention discloses the use of Heminth Defense Molecules in methods and compositions for modulating immune responses including treating or preventing undesirable or deleterious immune responses.

Abstract: A process for forming high surface area graphene structures includes: depositing at least one metal on a surface of silicon carbide; heating the at least one metal and the silicon carbide to cause at least one of the metals to react with a portion of the silicon carbide to form silicide regions extending into an unreacted portion of the silicon carbide and graphene disposed between the silicide regions and the unreacted portion of the silicon carbide; and removing the silicide regions to provide a silicon carbide structure having a highly irregular surface and a surface layer of graphene.

Abstract: The present invention relates generally to a population of cells genetically modified to produce insulin in a glucose responsive manner and uses thereof. More particularly, the present invention relates to a population of cells genetically modified to produce insulin in response to physiologically relevant levels of glucose and uses thereof. The cells of the present invention are useful in a wide variety of applications, in particular in the context of therapeutic and prophylactic regimes directed to the treatment of diabetes and/or the amelioration of symptoms associated with diabetes, based on the transplantation of the cells of the present invention into mammals requiring treatment. Also facilitated is the design of in vitro based screening systems for testing the therapeutic effectiveness and/or toxicity of potential adjunctive treatment regimes.

Abstract: The present disclosure generally relates to nanoparticles adsorbed with gliadin molecules. In addition, the present disclosure relates to methods of preparing the nanoparticles adsorbed with gliadin molecules and methods of using said nanoparticles including detecting anti-gliadin 5 antibodies in a sample, diagnosing gluten-related disorders, and other applications.

Abstract: The present invention relates to methods for the treatment or prevention of asbestos related diseases, in particular mesothelioma and asbestosis, and further to methods for the treatment or prevention of asbestos-induced DNA damage. These methods involve administration to a subject in need thereof compositions comprising zeolite or zeolite-like materials such as clinoptilolite.

Abstract: An object tracking device includes a short-term processing portion and a long short-term processing portion that are implemented by circuitry and work in a collaborative manner to track an object. The short-term processing portion includes a filter that tracks the object based on short-term memory and spatiotemporal consistency. The long short-term processing portion performs key-point matching-tracking and estimation based on a key-point database in order to track the object. A controller determines an output of the object tracking device based on the processing conducted by the short-term and long short-term processing portions of the tracking device, respectively.

Abstract: Methods and systems estimate cardio-respiratory parameter(s), such as from in-phase and quadrature channels. The channels may represent patient chest movement and may be generated with a sensor, such as a contactless sensor that may sense movement with radio-frequency signals. In the methods/systems, the in-phase and quadrature channels may be processed, such as in a processor(s), using relative demodulation to generate cardio-respiratory parameter estimate(s). Optionally, the processing produces a jerk signal that may be filtered for producing a heart rate estimate, such as from zero-crossings of the filtered signal. Optionally, the processing produces a chest velocity signal that may be filtered for producing a respiratory rate estimate, such as from zero-crossings of the filtered signal.

Abstract: A system for selective anchoring a climbing vehicle or robot to a surface of a structure. The system includes a foot (1) having at least one surface contacting toe assembly (2). The toe assembly includes a magnetic adhesion system transitionable between an engageable state, wherein said adhesion system is configured to actively hold said toe to the surface on a plane of engagement thereby anchoring said foot to the structure, and a disengageable state to allow detachment of said foot from said surface. The adhesion system includes a magnetic field generator for projecting a magnetic field outwardly from the plane of engagement toward said engaged surface when the adhesion system is in the engageable state, to thereby generate a magnetic attractive force between the module and a magnetic target material within or beneath the surface of the structure.

Abstract: Described herein are devices, frameworks and methodologies configured to enable monitoring and analysis of dwell time in respect of a human conveyance. Embodiments of the invention have been particularly developed for monitoring and analysis of dwell time in respect of trains. In some examples, the technology makes use of depth-sensitive sensor equipment to monitor activity in three dimensions, including train and passenger and activity, thereby to identify artefacts of dwell time events.

Abstract: The present invention relates generally to a population of cells genetically modified to produce insulin in a glucose responsive manner and uses thereof. More particularly, the present invention relates to a population of cells genetically modified to produce insulin in response to physiologically relevant levels of glucose and uses thereof. The cells of the present invention are useful in a wide variety of applications, in particular in the context of therapeutic and prophylactic regimes directed to the treatment of diabetes and/or the amelioration of symptoms associated with diabetes, based on the transplantation of the cells of the present invention into mammals requiring treatment. Also facilitated is the design of in vitro based screening systems for testing the therapeutic effectiveness and/or toxicity of potential adjunctive treatment regimes.

Abstract: An object tracking device includes a short-term processing portion and a long short-term processing portion that are implemented by circuitry and work in a collaborative manner to track an object. The short-term processing portion includes a filter that tracks the object based on short-term memory and spatiotemporal consistency. The long short-term processing portion performs key-point matching-tracking and estimation based on a key-point database in order to track the object. A controller determines an output of the object tracking device based on the processing conducted by the short-term and long short-term processing portions of the tracking device, respectively.

Abstract: The present invention relates to new omega-3 fatty acid analogues and to their use in cancer therapy, including anti-metastatic therapy.

Abstract: An object tracking device includes a short-term processing portion and a long short-term processing portion that are implemented by circuitry and work in a collaborative manner to track an object. The short-term processing portion includes a filter that tracks the object based on short-term memory and spatiotemporal consistency. The long short-term processing portion performs key-point matching-tracking and estimation based on a key-point database in order to track the object. A controller determines an output of the object tracking device based on the processing conducted by the short-term and long short-term processing portions of the tracking device, respectively.

Abstract: A method of tracking a target object in frames of video data includes receiving a first tracking position associated with the target object in a first frame of a video sequence; identifying, for a second frame of the video sequence, a plurality of representation levels and at least one node for each representation level; determining, by a processor, a second tracking position in the second frame by estimating motion of the target object in the second frame between the first frame and the second frame; determining, at each representation level by the processor, a value for each node based on a conditional property of the node in the second frame; and adjusting, by the processor, the second tracking position based on the values determined for each of the nodes and interactions between at least some of the nodes at different representation levels.

Abstract: An object tracking device includes a short-term processing portion and a long short-term processing portion that are implemented by circuitry and work in a collaborative manner to track an object. The short-term processing portion includes a filter that tracks the object based on short-term memory and spatiotemporal consistency. The long short-term processing portion performs key-point matching-tracking and estimation based on a key-point database in order to track the object. A controller determines an output of the object tracking device based on the processing conducted by the short-term and long short-term processing portions of the tracking device, respectively.

Abstract: The present invention relates generally to a population of cells genetically modified to produce insulin in a glucose responsive manner and uses thereof. More particularly, the present invention relates to a population of cells genetically modified to produce insulin in response to physiologically relevant levels of glucose and uses thereof. The cells of the present invention are useful in a wide variety of applications, in particular in the context of therapeutic and prophylactic regimes directed to the treatment of diabetes and/or the amelioration of symptoms associated with diabetes, based on the transplantation of the cells of the present invention into mammals requiring treatment. Also facilitated is the design of in vitro based screening systems for testing the therapeutic effectiveness and/or toxicity of potential adjunctive treatment regimes.